What is the stepwise approach to investigating primary immunodeficiencies in children for general pediatricians?

Stepwise Investigations for Primary Immunodeficiencies in Children for General Pediatricians

General pediatricians should follow a tiered diagnostic approach starting with inexpensive screening tests, progressing to advanced testing only when screening results are abnormal, and maintaining high clinical suspicion based on specific infection patterns and associated clinical features 1.

Initial Clinical Recognition

Before ordering any laboratory tests, recognize the warning signs that should trigger investigation:

High-Risk Clinical Presentations

• SCID: Failure to thrive, chronic diarrhea, severe/disseminated infections, opportunistic infections (especially Pneumocystis), persistent rash, abnormal newborn TREC screen 1
• Antibody deficiencies: Recurrent sinopulmonary infections with encapsulated bacteria (pneumococcus, H. influenzae), recurrent viral respiratory and gastrointestinal infections 1
• Phagocytic defects (CGD): Deep-seated infections, abscesses with granuloma formation 1
• Complement deficiencies: Recurrent Neisseria infections, autoimmunity 1
• Immune dysregulation: Autoimmunity, lymphoproliferation, hemophagocytic lymphohistiocytosis 1

Critical Family History Elements

Thoroughly evaluate for family members with early deaths from infection, consanguinity, or similar recurrent infections—this significantly raises suspicion and may warrant immediate screening even before severe infections develop 1.

Step 1: First-Line Screening Tests

These are inexpensive, rapid, and reasonably sensitive/specific 1:

For All Suspected Cases

• Complete blood count with differential: Assess absolute lymphocyte count, neutrophil count, and platelet count 1
• Serum immunoglobulin levels: IgG, IgA, IgM (age-adjusted reference ranges are critical) 1
• Total hemolytic complement (CH50): Screens classical pathway 1
• Alternative pathway hemolytic activity (AH50): Screens alternative pathway 1

When Cellular Immunity Suspected

• Flow cytometry for lymphocyte subsets: Enumerate CD4+ T cells, CD8+ T cells, B cells (CD19+), and NK cells 1
• TREC newborn screening: If available and not already done 1

Step 2: Functional Assessment of Specific Immunity

Measuring serum immunoglobulins alone is insufficient—you must assess functional antibody responses 1.

Humoral Function Testing

• Specific antibody titers to protein antigens: Tetanus, diphtheria toxoids (measures T-cell dependent responses) 1
• Specific antibody titers to polysaccharide antigens: Pneumococcal serotypes (measures T-cell independent responses) 1
  • If inadequate response, consider booster immunization and recheck in 4-6 weeks
  • Critical caveat: Do not give live vaccines if T-cell deficiency suspected 1

When to Skip Antibody Testing

In patients with findings consistent with agammaglobulinemia (very low/absent IgG, IgA, IgM), measurement of specific antibody responses is unnecessary 1.

Step 3: Advanced Testing (When Screening Abnormal)

For Antibody Deficiencies

• Flow cytometry for B-cell subsets: Enumerate naive and switched memory B cells 1
• IgG subclasses: Only if recurrent respiratory infections with normal total IgG, IgA, IgM 1
  • Important limitation: Measure all 4 subclasses simultaneously
  • Confirm abnormalities with repeat testing ≥1 month apart
  • Do not diagnose IgG4 deficiency before age 10 years (normally very low in young children) 1

For Cellular Deficiencies

• In vitro proliferative response to mitogens and antigens 1
• T-cell subset analysis: Naive, memory, activated cells 1
• Cytokine production assays: In response to specific stimuli 1

For Phagocytic Defects

• Dihydrorhodamine (DHR) reduction test or nitroblue tetrazolium: Screens for CGD 1
• Flow cytometry for adhesion molecules: Evaluates leukocyte adhesion deficiency 1
• Chemotaxis and phagocytosis assays 1

For Complement Deficiencies

• Individual complement component levels: When CH50 or AH50 abnormal 1
• Lectin pathway function testing 1

Step 4: Genetic Testing

When to Pursue

• After abnormal screening/advanced tests identify specific immune defect
• Strong family history with consanguinity
• Syndromic features suggesting specific diagnosis 1

Approach

• Targeted gene sequencing: When specific diagnosis suspected (e.g., BTK for X-linked agammaglobulinemia)
• Microarray for copy number variation: Screens for deletions/duplications 1
• Next-generation sequencing panels: When diagnosis unclear but immunodeficiency confirmed 2

Critical Pitfalls to Avoid

1. Do not measure IgG subclasses routinely: By definition, 2.5% of normal population will be "deficient" in at least one subclass 1. Only measure when total immunoglobulins are normal but clinical suspicion remains high.

2. Do not diagnose based on single abnormal value: Confirm all abnormalities with repeat testing 1.

3. Do not give live vaccines when T-cell deficiency suspected: This can cause disseminated vaccine-strain infection 1.

4. Do not overlook secondary causes: Medications (antiepileptics, immunosuppressants), protein loss (nephrotic syndrome, protein-losing enteropathy), HIV, malignancy can all cause hypogammaglobulinemia 1, 3.

5. Age-appropriate reference ranges are mandatory: Immunoglobulin levels and lymphocyte counts vary significantly with age 1.

When to Refer to Immunology Specialist

• Any abnormal screening test result
• Strong clinical suspicion despite normal screening tests
• Need for advanced functional testing
• Consideration of immunoglobulin replacement therapy
• Genetic counseling needs 1